Leukemia Diagnostics
Standardized protocols for RQ-PCR residual disease analysis developed
Published in Blood Weekly, April 22nd, 2004
"Detection of minimal residual disease (MRD) has proven to provide independent prognostic information for treatment stratification in several types of leukemias such as childhood acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML) and acute promyelocytic leukemia," explained oncologists in France, who examined "the accurate quantitative measurement of fusion gene (FG) transcripts as can be applied in 35-45% of ALL and acute myeloid leukemia, and in more than 90% of CML."
"A total of 26 European university laboratories from 10 countries have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-04-22)
More Articles from Blood Weekly
- Leukemia Therapy
Specific T-cell replete haploidentical SCT feasible for pediatric ALL - Stem-Cell Transplantation
Recipient CMV status should determine T-cell depletion - Chronic Myelogenous Leukemia Therapy
Cytogenetic CE alone does not reduce post-SCT imatinib efficacy - Paroxysmal Nocturnal Hemoglobinuria
Membranous glomerulopathy reported after allo-SCT in PNH patient - Stem-Cell Transplantation
Fatal post-SCT androgen-related hepatic adenoma described - Stem-Cell Transplantation
Reservation of PBSCs for DLI at harvest improves postrelapse treatment efficacy - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
